A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)
Clinical trial NCT07037875 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07037875
- Sponsor
- Cinclus Pharma Holding AB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-11
- Primary completion
- 2026-08-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.